The investigation of stable nitric oxide (NO) metabolites correlation in exhaled breath condensate (EBC) in Chernobyl clean-up workers (CCUW) with COPD Source: Annual Congress 2011 - Work-related respiratory diseases and specific exposures Year: 2011
The dynamics of Fe2+ and nitric oxide (NO) metabolites levels in exhaled breath condensate (EBC) in long-term smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
Time course of exhaled hydrogen peroxide (H2 O2 ) and nitric oxide (eNO) during chemotherapy in patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 92s Year: 2005
Relationship between basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) and oxygenation parameters in ventilated patients undergoing cardiopulmonary bypass (CPB) Source: Eur Respir J 2004; 24: Suppl. 48, 264s Year: 2004
Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Natural allergen exposure and nitric oxide (NO) metabolites in exhaled air condensate (EAC) of children with mite bronchial asthma (BA) Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003
Flexible bronchoscopy (FB) does not influence the concentrations of exhaled nitric oxide (eNO) measured 24 hours after the procedure Source: Eur Respir J 2006; 28: Suppl. 50, 608s Year: 2006
Changes in nitric oxide (NO) cycle metabolites in children with mild asthma (BA) receiving STEP-2 therapy Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Nitric oxide metabolites and total IgE in exhaled air condensate (EAC) of the patients with bronchial asthma (BA) and allergen exposure Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004
Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy. Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Diagnostic use of exhaled nitric oxide (eNO) after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Salt chamber treatment had no effect on fractional exhaled nitric oxide (FeNO) in patients with symptoms suggesting asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Reproducibility of exhaled nitric oxide (NO) measured by multiple exhalation flow technique (MEFT) in adults Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
Adult asthma, fraction of exhaled nitric oxide (FENO ), and lung function Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009
Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung? Source: Eur Respir J 2001; 18: Suppl. 33, 179s Year: 2001
The cost and benefits of exhaled nitric oxide (NO) measurement in asthma - The results from three years follow-up study Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018